COVID-19 Update

All university offices have resumed in-person operations. Students, faculty & staff must be fully vaccinated or have an approved exemption to return to campus in the fall.

Kari Debbink - Publications

< Return to biography page

  • Ealy AM, Debbink K. (2020) “Viral Diversity, Evolution, and Selective Pressure.” in N.M. Melham (Ed.), Noroviruses. Springer, Inc.
  • Lindesmith LC, Brewer-Jensen P, Mallory M, Yount B, Collins M, Debbink K, Baric RS. (2019) “Human norovirus epitope D plasticity allows escape from antibody immunity without loss of capacity for binding cellular ligands”. J. Virology. PMID: 30355694
  • Goo L, Debbink K, Kose N, Sapparapu G, Doyle MP, Wessel AW, Richner JM, Burgomaster KE, Larman BC, Dowd KA, Diamond MS, Crowe JE Jr, Pierson TC. (2019) “A protective human monoclonal antibody targeting the West Nile virus E protein preferentially recognizes mature virions.” Nature Microbiology. PMID: 30455471.
  • Kocher JF, Lindesmith LC, Debbink K, Beall A, Mallory ML, Yount BL, Graham RL, Huynh J, Gates JE, Donaldson EF, Baric RS. (2018)Bat caliciviruses and human noroviruses are antigenically similar and have overlapping histo-blood group antigen binding profiles”. mBio https://doi.org/10.1128/mBio.00869-18
  • Lindesmith LC, Mallory ML, Debbink K, Donaldson EF, Brewer-Jensen PD, Swann EW, Sheahan TP, Graham RL, Beltramello M, Corti D, Lanzavecchia A, Baric RS. (2018) “Conformational Occlusion of Blockade Antibody Epitopes, a Novel Mechanism of GII.4 Human Norovirus Immune Evasion.” mSphere. PMID: 29435493
  • Lindesmith LC, Brewer-Jensen PD, Mallory ML, Debbink K, Swann EW, Vinje J, Baric RS. (2018) “Antigenic Characterization of a Novel Recombinant GII.P16-GII.4 Sydney Norovirus Strain with Minor Sequence Variation Leading to Antibody Escape.” J Infect. Dis. PMID: 29281104
  • Widman DG, Young E, Nivarthi U, Swanstrom JA, Royal SR, Yount BL, Debbink K, Begley M, Marcet S, Durbin A, de Silva AM, Messer WB, Baric RS. (2017) “Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4.” Sci Reports. PMID: 29215033
  • Menachery VD, Gralinski LE, Dinnon KH, Mitchell HD, Dinnon KD, Leist SR, Yount BL, Graham RL, McAnarney ET, Stratton KG, Debbink K, Sims AC, Waters KM, Baric RS. (2017) “MERS-CoV NSP16 necessary for IFN resistance and viral pathogenesis.” MSphere. PMID: 29152578
  • Lindesmith LC, Kocher JF, Debbink K, Donaldson EF, Mallory ML, Swann EW, Brewer-Jenson PD, Baric RS. (2017) “Emergence of Novel Human Norovirus GII.17 Strains Correlates with Changes in Blockade Antibody Epitopes.” J Infect Dis. PMID: 28973354
  • Debbink K, McCrone JT, Petrie JG, Truscon R, Johnson E, Mantlo E, Monto AS, Lauring AS. (2017) “Vaccination has minimal impact on the intrahost diversity of H3N2 influenza viruses.” PLOS Pathogens. PMID: 28141862   *indicates undergraduate mentee
  • Anthony SJ, Gilardi K, Goldstein T, Ssebide B, Mbabazi R, Navarrete-Macias I, Liang E, Wells H, Hicks A, Petrosov A, Byarugaba DK, Debbink K, Yount BL, Menachery VD, Cranfield M, Johnson CK, Baric RS, Lipkin WI, Mazet JAK. (2017) “Further evidence for bats as the evolutionary source of MERS Coronavirus” MBio, PMID: 28377531.
  • Menachery VD, Yount BL,  Sims AC,  Agnihothram S,  Debbink K,  Gralinski LE,  Plante JA,  Graham RL, Scobey T,  Royal S,  Swanstrom J,  Sheahan T,  Pickles RJ,  Corti D,  Randell SH,  Lanzavecchia A,  Marasco WA, Baric RS. (2016) “SARS-like WIV1-CoV poised for human emergence.” PNAS, PMID: 26976607.
  • Menachery VD, Yount BL, Debbink K, Agnihothram S, Gralinski LE, Graham RL, Scobey T, Donaldson EF, Ge ZY, Randell SH, Lanzavecchia A, Marasco WA, Shi ZL, Baric RS. (2015) "SARS-like cluster of circulating bat coronaviruses pose threat for human emergence.” Nature Med. DOI: 10.1038/nm.3985
  • Debbink K. (2015) "Virus-like particles as future norovirus vaccines.” Future Virology. 8:10, 925-27.
  • Debbink, K. (2015) “Ancestry-based differences in norovirus susceptibility: implications for understanding global infection patterns.” Clin. Infect. Dis. PMID: 25744497.
  • Lindesmith LC, Ferris MT, Mullan CW, Ferreira J, Debbink K, Swanstrom J, Richardson C, Goodwin RR, Baehner F, Mendelman PM, Bargatze RF, Baric RS. (2015) “Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial.” PLoS Med. PMID: 25803642.
  • Debbink K, Lindesmith LC, Donaldson EF, Swanstrom J, Baric RS. (2014) “A Chimeric VLP-based Norovirus Vaccine Induces a Broadly Blocking Immune Response.” J Virology, PMID 24741081.
  • Debbink K, Lindesmith LC, Baric RS. (2014) “The State of Norovirus Vaccines.” Clin. Infect Dis.                PMID: 24585561.
  • Debbink K, Lindesmith LC, Ferris MT, Swanstrom J, Beltramello M, Corti D, Lanzavecchia A, Baric RS. (2014) “Within Host Evolution Results in Antigenically Distinct GII.4 Noroviruses.” J Virology, PMID: 24648459.
  • Menachery VD, Debbink K, and Baric RS. (2014) “Coronavirus Non-Structural Protein 16: Evasion, Attenuation, and Possible Treatments” Virus Research. PMID: 25278144.
  • Lindesmith LC, Donaldson EF, Beltramello M, Pintus S, Corti D, Swanstrom J, Debbink K, Jones TA, Lanzavecchia A, Baric RS. (2014) “Particle Conformation Regulates Antibody Access to a Conserved GII.4 Norovirus Blockade Epitope.” J Virology, PMID 24872579.
  • Debbink K, Lindesmith LC, Donaldson EF, Costantini V, Beltramello M, Corti D, Lanzavecchia A, Vinje J, Baric RS. (2013) “Emergence of New Pandemic GII.4 Sydney Norovirus Strain Correlates with Escape From Herd Immunity.” J Infect Dis., PMID: 23908476.
  • Debbink, K, Costantini V, Swanstrom J, Agnihothram S, Vinje J, Baric RS, Lindesmith LC. (2013). “Human Norovirus Detection and Production, Quantification, and Storage of Virus-Like Particles.” Curr Protoc Microbiol., PMID: 24510290.
  • Lindesmith LC, Constantini V, Swanstrom J, Debbink K, Donaldson EF, Vinje J, Baric RS. (2013) “Emergence of a Norovirus GII.4 Strain Correlates with Changes in Evolving Blockade Epitopes.”  J Virology, 87(5):2803-13.
  • Debbink K, Lindesmith LC, Donaldson EF, Baric RS. (2012) “Norovirus Immunity and the Great Escape”  PLoS Pathogens, 8(10): e1002921.
  • Debbink K, Donaldson EF, Lindesmith L, Baric RS. (2012) “Genetic Mapping of a Highly Variable Norovirus GII.4 Blockade Epitope: Potential Role in Escape from Human Herd Immunity.”  J Virology, 86(2):1214.
  • Lindesmith LC, Beltramello M, Donaldson EF, Corti D, Swanstrom J, Debbink K, Lanzavecchia A, Baric RS. (2012) “Immuogenetic Mechanisms Driving Norovirus GII.4 Antigenic Variation.”  PLoS Pathogens, 8(5):e1002705.
  • Lindesmith, L, Debbink K, Swanstrom J, Vinje J, Costantini V, Baric RS, Donaldson EF. (2012) “Monoclonal Antibody Based Antigenic Mapping of Norovirus GII.4-2002.” J Virology, 86(2):873.
  • Pulicherla, N., Shen S, Yadav S., Debbink K, Govindasamy L, Agbandje-McKenna M, Asokan, A. (2011) “Engineering liver-detargeted AAV9 vectors for cardiac and musculoskeletal gene transfer.” Mol. Ther. 19(6):1070-8.